Form 4 holding
Director
Cocrystal Pharma, Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 24,615
- Estimated value
- Report date
- 09 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount